A “Pure Play” Biologics Swiss-based CDMO

by Biotech Newsroom


The Celonic Group is a fast rising, mid-sized biologics CDMO focusing uniquely on mammalian expressed drugs. It provides end to end drug substance development and manufacturing solutions for monoclonal antibodies, bispecifics and other complex molecules from development all the way to commercial supply. Celonic combines the expertise like larger CDMOs with the agility and a collaboration mindset of a family owned business. The Celonic Group is privately-owned and part of the independent German family business J. Rettenmaier & Söhne Group (JRS). Celonic’s history is a success story. Over 30 years, the company has continuously expanded from…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC